Month: June 2022

TORONTO, June 15, 2022 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX:YRI; NYSE:AUY; LSE:AUY) (“Yamana” or “the Company”) has published its 2021 Sustainability Report. This provides a comprehensive overview of Yamana’s environmental, social, and governance (“ESG”) performance, alongside the approach and philosophy that underpins the Company’s commitment to ESG excellence. Highlights:The adoption of a Responsibility Policy and eight Statements of Commitment describing the Company’s statements of principle and intent, covering all functional aspects of Health, Safety and Sustainable Development. The continuing work to limit the impact of COVID-19 on the Company’s workforce, host communities and business, including the high vaccination rates that have been achieved in all operating jurisdictions. The commitment to reduce greenhouse gas...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) is pleased to announce that it is undertaking a marketed public offering of units of the Company (the “Units” or the “Offered Securities”) with Research Capital Corporation as the sole agent and sole bookrunner (the “Agent”), in each of the provinces of Canada (other than Quebec) (the “Offering”). The size of the Offering and price of the Units will be determined in the context of the market. Each Unit will consist of one Class A common share of the Company (a “Common Share“) and one Common Share purchase warrant of the Company (a “Warrant“). Each Warrant entitles...

VANCOUVER, June 15, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the appointment of Mr. Alan Rootenberg as Chief Financial Officer, effective June 14, 2022. The Company thanks Mr. Oded Gilboa for his contribution to the Company, as CFO. Mr. Gilboa has also left his role as a director of the company.  About Clearmind Inc. (CSE: CMND), (OTC: CMNDF), (FSE: CWY0) Clearmind is a biotech company focused on the discovery and development of safe and novel psychedelic-derived therapeutics to treat alcohol use disorder and other pressing health challenges. The Israeli Canadian company holds several...

VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI; OTCQB: RSSFF), a vertical farming technology and operations company with a commercial production facility in Abbotsford, BC, is pleased to announce that further to its news release dated June 8, 2022, the Company will consolidate the common shares in the capital of the Company (the “Shares”) on the basis of one (1) post-consolidated Share for each ten (10) pre-consolidated Shares with an effective date of June 20, 2022 (the “Consolidation”). The name of the Company and the trading symbol will remain the same after the Consolidation. Following the Consolidation, the Company’s new CUSIP number will be 00830Q306 and the new ISIN number will be CA00830Q3061. The Company’s post-Consolidation Shares are expected...

TORONTO, June 15, 2022 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (the “Corporation” or “Doré Copper“) (TSXV: DCMC; OTCQX: DRCMF; FRA: DCM) is pleased to announce that further to its news releases dated May 10, 2022, it has filed a technical report titled “Preliminary Economic Assessment for the Chibougamau Hub-and-Spoke Complex, Québec, Canada” in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects (“NI 43-101”) A copy of the technical report is available on the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at https://www.dorecopper.com. The Technical Report focuses on the results of the PEA which includes the Corner Bay, Devlin, and Joe Mann projects feeding the Company’s centralized Copper Rand mill, all located in...

PITTSBURGH, June 15, 2022 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas (“RNG”), today announced that it will join the broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, according to a preliminary list of additions posted June 3.   In addition, Montauk Renewables was recently added to the MSCI Global Small Cap Indexes within the MSCI USA Small Cap Index, which became effective after the market close on May, 31, 2022. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 6, ranking them by total market capitalization. Membership...

ONTARIO, Calif., June 15, 2022 (GLOBE NEWSWIRE) — CVB Financial Corp. (“CVBF”), the holding company for Citizens Business Bank (“CBB”), is pleased to announce the appointment of Kimberly Sheehy as a Board Member. Ms. Sheehy was also named a Director of CBB. Her appointment increases the current total authorized board members for each of CVBF and CBB from eight to nine. Ms. Sheehy will serve as Chair of CVBF’s Audit Committee and as a member of CVBF’s Compensation Committee and Nominating and Corporate Governance Committee, in addition to serving as a member of CBB’s Risk Management Committee, Balance Sheet Management Committee and Trust Services Committee. “We are very pleased to welcome Kim Sheehy to join our Boards of Directors,” said Hal W. Oswalt, Chairman of the Boards of CVBF and CBB. “Kim’s recognized expertise in finance,...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021 GATINEAU, Quebec, June 15, 2022 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) is pleased to announce that at its special meeting of shareholders held yesterday (the “Meeting“), holders (“Shareholders“) of common shares of HEXO (“Common Shares“) overwhelmingly approved the previously announced equity purchase agreement (the “Standby Agreement”) with 2692106 Ontario Inc. (the “Investor”) and KAOS Capital Ltd. A total of 73,880,016 Common Shares (approximately 16.12% of the issued and outstanding Common Shares) were represented at the...

New modern luxury community features stunning architectural and interior designEdgewood East by Toll Brothers The model home at Edgewood East by Toll Brothers in East Cobb is now open, showcasing the community’s stunning architectural and interior design.Edgewood East by Toll Brothers “The newly-opened Edgewood East model home serves as an inspiration for our home buyers who are looking for a spacious retreat to call home in heart of East Cobb,” said Eric White, Division President of Toll Brothers in Atlanta.MARIETTA, Ga., June 15, 2022 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of its model home at Edgewood East, a new community of luxury homes in East Cobb. The sales center and model home are located at 4817 Wigley Road in Marietta,...

Mean Baseline Adjusted Epinephrine Concentration over 0-2h by Treatment, Part 3 Mean Baseline Adjusted Epinephrine Concentration over 0-2h by Treatment, Part 3AQST-109 is the first and only orally delivered epinephrine product candidate in clinical development Fastest median time to maximum concentration (Tmax) in studies to date at 12 minutes Study continues to show AQST-109 is safe and well tolerated Head-to-head comparison study to EpiPen® scheduled to commence in third quarter 2022 On track to request End-of-Phase 2 meeting with FDA in fourth quarter 2022 and thereafter to commence pivotal PK study Remaining data from Part 3 expected to be reported in early third quarter 2022WARREN, N.J., June 15, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve...